Literature DB >> 2353479

Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.

G R Birchfield1, J H Ward, B G Redman, L Flaherty, W E Samlowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2353479      PMCID： PMC1002442     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  11 in total

Review 1.  Acute pancreatitis.

Authors:  J R Potts
Journal:  Surg Clin North Am       Date:  1988-04       Impact factor: 2.741

Review 2.  Interleukin 2.

Authors:  K A Smith
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 3.  Drug-induced pancreatitis: a critical review.

Authors:  A Mallory; F Kern
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

4.  Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.

Authors:  M Estrin; S A Huber
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

5.  Colonic perforation. An unusual complication of therapy with high-dose interleukin-2.

Authors:  D Schwartzentruber; M T Lotze; S A Rosenberg
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

Review 6.  Acute pancreatitis.

Authors:  M C Geokas; H A Baltaxe; P A Banks; J Silva; C F Frey
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

7.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Authors:  S A Rosenberg; M T Lotze; L M Muul; S Leitman; A E Chang; S E Ettinghausen; Y L Matory; J M Skibber; E Shiloni; J T Vetto
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

8.  Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.

Authors:  B T Gemlo; M A Palladino; H S Jaffe; T P Espevik; A A Rayner
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

Review 9.  NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

Authors:  S A Rosenberg; M T Lotze; J J Mulé
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

10.  Clinical effects and toxicity of interleukin-2 in patients with cancer.

Authors:  M T Lotze; Y L Matory; A A Rayner; S E Ettinghausen; J T Vetto; C A Seipp; S A Rosenberg
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860
View more
  4 in total

Review 1.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

Review 2.  Clinical toxicity of interleukin-2.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 3.  Ever-increasing diversity of drug-induced pancreatitis.

Authors:  Simcha Weissman; Muhammad Aziz; Ryan B Perumpail; Tej I Mehta; Rutwik Patel; James H Tabibian
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

4.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.